$CWAN
Clearwater Analytics Holdings, Inc. Stock $cwan

$cwan Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000162828024007825 Filed on February 29, 2024

Income Statement

Concept	2023 Q4	2023	2022
Revenue	$99.02M	$368.2M	$303.4M
YoY Change	19.75%	21.34%	20.4%
Cost Of Revenue	$28.34M	$107.1M	$87.78M
YoY Change	23.34%	22.03%	29.35%
Gross Profit	$70.68M	$261.0M	$215.6M
YoY Change	18.37%	21.05%	17.1%
Gross Profit Margin	71.38%	70.9%	71.07%
Selling, General & Admin	$34.37M	$153.9M	$116.4M
YoY Change	9.84%	32.18%	40.24%
% of Gross Profit	48.62%	58.94%	53.98%
Research & Development	$33.73M	$123.9M	$94.12M
YoY Change	37.37%	31.67%	29.48%
% of Gross Profit	47.72%	47.47%	43.65%
Depreciation & Amortization	$2.593M	$9.929M	$5.139M
YoY Change	58.11%	93.21%	47.12%
% of Gross Profit	3.67%	3.8%	2.38%
Operating Expenses	$68.09M	$277.8M	$210.5M
YoY Change	21.95%	31.95%	35.21%
Operating Profit	$2.590M	-$16.75M	$5.117M
YoY Change	-33.16%	-427.24%	-82.02%
Interest Expense	$1.979M	$6.401M	$1.137M
YoY Change	55.09%	462.97%	-95.57%
% of Operating Profit	76.41%		22.22%
Other Income/Expense, Net	-$7.615M	$1.874M	$50.00K
YoY Change	13.37%	3648.0%	-160.24%
Pretax Income	-$3.046M	-$22.87M	-$5.335M
YoY Change	94.51%	328.6%	-29.87%
Income Tax	$401.0K	$217.0K	$1.360M
% Of Pretax Income
Net Earnings	-$4.433M	-$21.63M	-$7.967M
YoY Change	49.66%	171.46%	-3.0%
Net Earnings / Revenue	-4.48%	-5.87%	-2.63%
Basic Earnings Per Share		-$0.11	-$0.04
Diluted Earnings Per Share	-$0.02	-$0.11	-$0.04
COMMON SHARES
Basic Shares Outstanding		199.7M shares	185.6M
Diluted Shares Outstanding		199.7M shares	185.6M

Balance Sheet

Concept	2023 Q4	2023	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$296.2M	$296.2M	$255.6M
YoY Change	15.89%	15.89%	0.4%
Cash & Equivalents	$221.8M	$221.8M	$250.7M
Short-Term Investments	$74.46M	$74.46M	$4.890M
Other Short-Term Assets	$959.0K	$18.84M	$21.50M
YoY Change	-58.93%	-12.37%	29.88%
Inventory
Prepaid Expenses	$11.23M
Receivables	$92.09M	$94.86M	$75.09M
Other Receivables	$1.692M	$6.074M	$4.142M
Total Short-Term Assets	$416.0M	$416.0M	$356.3M
YoY Change	16.74%	16.74%	10.89%
LONG-TERM ASSETS
Property, Plant & Equipment	$15.35M	$37.90M	$39.18M
YoY Change	1.89%	-3.25%	264.85%
Goodwill	$45.34M
YoY Change	3.53%
Intangibles	$26.13M
YoY Change	-11.28%
Long-Term Investments	$21.50M	$21.50M
YoY Change
Other Assets	$4.907M	$9.970M	$11.98M
YoY Change	-16.55%	-16.78%	-2.44%
Total Long-Term Assets	$142.7M	$142.7M	$125.6M
YoY Change	13.66%	13.66%	445.67%
TOTAL ASSETS
Total Short-Term Assets	$416.0M	$416.0M	$356.3M
Total Long-Term Assets	$142.7M	$142.7M	$125.6M
Total Assets	$558.7M	$558.7M	$481.9M
YoY Change	15.94%	15.94%	39.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.062M	$3.062M	$3.092M
YoY Change	-0.97%	-0.97%	118.36%
Accrued Expenses	$47.57M	$47.57M	$41.86M
YoY Change	13.63%	13.63%	82.77%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.750M	$2.750M	$2.750M
YoY Change	0.0%	0.0%	0.0%
Total Short-Term Liabilities	$80.79M	$80.79M	$66.01M
YoY Change	22.39%	22.39%	111.59%
LONG-TERM LIABILITIES
Long-Term Debt	$45.83M	$45.83M	$48.49M
YoY Change	-5.49%	-5.49%	-5.21%
Other Long-Term Liabilities	$5.518M	$17.11M	$23.12M
YoY Change	-42.2%	-25.99%	17415.15%
Total Long-Term Liabilities	$5.518M	$62.94M	$71.61M
YoY Change	-42.2%	-12.11%	39.62%
TOTAL LIABILITIES
Total Short-Term Liabilities	$80.79M	$80.79M	$66.01M
Total Long-Term Liabilities	$5.518M	$62.94M	$71.61M
Total Liabilities	$149.1M	$204.4M	$212.4M
YoY Change	3.85%	-3.77%	44.03%
SHAREHOLDERS EQUITY
Retained Earnings	-$181.3M
YoY Change	-2.85%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$354.3M	$354.3M	$269.5M
YoY Change
Total Liabilities & Shareholders Equity	$558.7M	$558.7M	$481.9M
YoY Change	15.94%	15.94%	39.95%

Cashflow Statement

Concept	2023 Q4	2023	2022
OPERATING ACTIVITIES
Net Income	-$4.433M	-$21.63M	-$7.967M
YoY Change	49.66%	171.46%	-3.0%
Depreciation, Depletion And Amortization	$2.593M	$9.929M	$5.139M
YoY Change	58.11%	93.21%	47.12%
Cash From Operating Activities	$24.10M	$84.60M	$58.01M
YoY Change	32.71%	45.85%	1627.37%
INVESTING ACTIVITIES
Capital Expenditures	$1.562M	$5.624M	$7.758M
YoY Change	-16.83%	-27.51%	54.39%
Acquisitions		$0.00	$65.79M
YoY Change		-100.0%
Other Investing Activities	$2.120M	-$89.43M	-$68.79M
YoY Change	-103.22%	30.0%
Cash From Investing Activities	$558.0K	-$95.06M	-$76.55M
YoY Change	-100.82%	24.17%	1423.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-9.367M	-$19.29M	16.23M
YoY Change	-187.05%	-218.87%	-91.69%
NET CHANGE
Cash From Operating Activities	24.10M	$84.60M	58.01M
Cash From Investing Activities	558.0K	-$95.06M	-76.55M
Cash From Financing Activities	-9.367M	-$19.29M	16.23M
Net Change In Cash	15.29M	-$28.96M	-3.873M
YoY Change	-139.45%	647.71%	-102.0%
FREE CASH FLOW
Cash From Operating Activities	$24.10M	$84.60M	$58.01M
Capital Expenditures	$1.562M	$5.624M	$7.758M
Free Cash Flow	$22.54M	$78.98M	$50.25M
YoY Change	38.42%	57.18%	-3114.22%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	6439000	usd
CY2023Q4	cwan	Tax Receivable Agreement Liability Noncurrent TaxReceivableAgreementLiabilityNoncurrent	18894000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	277786000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	5117000	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-25682000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	50000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7607000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7758000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5025000	usd
CY2023	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	3004000	usd
CY2022	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	3000000	usd
CY2023	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	124178000	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001866368
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.40
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-40838
CY2023	dei	Entity Registrant Name EntityRegistrantName	Clearwater Analytics Holdings, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-1043711
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	777 W. Main Street
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 900
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Boise
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	ID
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	83702
CY2023	dei	City Area Code CityAreaCode	208
CY2023	dei	Local Phone Number LocalPhoneNumber	433-1200
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	1387512053	usd
CY2023	dei	Auditor Name AuditorName	KPMG LLP
CY2023	dei	Auditor Location AuditorLocation	Boise, Idaho
CY2023	dei	Auditor Firm AuditorFirmId	185
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	221765000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	250724000	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	74457000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	4890000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	92091000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	72575000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	27683000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	28157000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	415996000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	356346000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15349000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15064000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	22554000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	24114000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	6563000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	533000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	728000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4907000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5880000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	26132000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	29456000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	45338000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	43791000	usd
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	21495000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	0	usd
CY2023Q4	us-gaap	Assets Assets	558743000	usd
CY2022Q4	us-gaap	Assets Assets	481942000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3062000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3092000	usd
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	49535000	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	42119000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2750000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2750000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6551000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5851000	usd
CY2022Q4	cwan	Tax Receivable Agreement Liability Noncurrent TaxReceivableAgreementLiabilityNoncurrent	12200000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	80792000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	66012000	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	45828000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	48492000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	16948000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	19505000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5518000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	9547000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	149086000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	143556000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	532507000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	455320000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2909000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	609000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-181331000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-186647000	usd
CY2023Q4	cwan	Members Equity And Stockholders Equity MembersEquityAndStockholdersEquity	354329000	usd
CY2022Q4	cwan	Members Equity And Stockholders Equity MembersEquityAndStockholdersEquity	269521000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	55328000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	68865000	usd
CY2023Q4	cwan	Members Equity And Stockholders Equity Including Portion Attributable To Noncontrolling Interest MembersEquityAndStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	409657000	usd
CY2022Q4	cwan	Members Equity And Stockholders Equity Including Portion Attributable To Noncontrolling Interest MembersEquityAndStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	338386000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	558743000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	481942000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	368168000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	303426000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	252022000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	107127000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	87784000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	67864000	usd
CY2023	us-gaap	Gross Profit GrossProfit	261041000	usd
CY2022	us-gaap	Gross Profit GrossProfit	215642000	usd
CY2021	us-gaap	Gross Profit GrossProfit	184158000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	123925000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	94120000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	72690000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	60365000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	52638000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	39065000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	93496000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	63767000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	43942000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	210525000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	155697000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	28461000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-10303000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-83000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-21627000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	199691873	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	199691873	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	185560683	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	185560683	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	177680507	shares
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	104447000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	65691000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	36695000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-23083000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-6695000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-8094000	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2744000	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	824000	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-102000	usd
CY2023	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent	42000	usd
CY2022	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent	0	usd
CY2021	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent	0	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-20297000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-5871000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-8196000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-970000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1453000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	17000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19327000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7324000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8213000	usd
CY2022Q4	cwan	Members Equity And Stockholders Equity Including Portion Attributable To Noncontrolling Interest MembersEquityAndStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	338386000	usd
CY2023	cwan	Stock Issued During Period Value Stock Options Exercised Net StockIssuedDuringPeriodValueStockOptionsExercisedNet	4738000	usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	2000	usd
CY2023	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	20784000	usd
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	4588000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	104957000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	2744000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	42000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-23083000	usd
CY2023	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	1933000	usd
CY2023	cwan	Effect Of Llc Unit Exchanges Value EffectOfLlcUnitExchangesValue	0	usd
CY2023Q4	cwan	Members Equity And Stockholders Equity Including Portion Attributable To Noncontrolling Interest MembersEquityAndStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	409657000	usd
CY2021Q4	cwan	Members Equity And Stockholders Equity Including Portion Attributable To Noncontrolling Interest MembersEquityAndStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	261868000	usd
CY2022	cwan	Stock Issued During Period Value Stock Options Exercised Net StockIssuedDuringPeriodValueStockOptionsExercisedNet	18284000	usd
CY2022	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	3189000	usd
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	4215000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	66236000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	824000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-6695000	usd
CY2022	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	3157000	usd
CY2022	cwan	Effect Of Llc Unit Exchanges Value EffectOfLlcUnitExchangesValue	0	usd
CY2022Q4	cwan	Members Equity And Stockholders Equity Including Portion Attributable To Noncontrolling Interest MembersEquityAndStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	338386000	usd
CY2020Q4	cwan	Members Equity And Stockholders Equity Including Portion Attributable To Noncontrolling Interest MembersEquityAndStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-344608000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1560000	usd
	cwan	Stock Repurchased During Period Value Net StockRepurchasedDuringPeriodValueNet	626000	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	2185000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	17981000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-101000	usd
	us-gaap	Profit Loss ProfitLoss	2829000	usd
CY2021Q4	cwan	Effect Of Organizational Transactions Value EffectOfOrganizationalTransactionsValue	0	usd
CY2021Q4	cwan	Adjustments To Additional Paid In Capital Allocation Of Equity To Non Controlling Interest AdjustmentsToAdditionalPaidInCapitalAllocationOfEquityToNonControllingInterest	0	usd
CY2021Q4	cwan	Stock Issued During Period Value Stock Options Exercised Net StockIssuedDuringPeriodValueStockOptionsExercisedNet	2571000	usd
CY2021Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	19230000	usd
CY2021Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1000	usd
CY2021Q4	us-gaap	Profit Loss ProfitLoss	-10923000	usd
CY2021Q4	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	169000	usd
CY2021Q4	cwan	Tax Adjustments Related To Organizational Transactions TaxAdjustmentsRelatedToOrganizationalTransactions	793000	usd
CY2021Q4	cwan	Members Equity And Stockholders Equity Including Portion Attributable To Noncontrolling Interest MembersEquityAndStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	261868000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-23083000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-6695000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-8094000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9929000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5139000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3493000	usd
CY2023	cwan	Noncash Operating Lease Cost NoncashOperatingLeaseCost	7619000	usd
CY2022	cwan	Noncash Operating Lease Cost NoncashOperatingLeaseCost	5950000	usd
CY2021	cwan	Noncash Operating Lease Cost NoncashOperatingLeaseCost	0	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	104447000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	65691000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	36695000	usd
CY2023	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	4763000	usd
CY2022	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	4327000	usd
CY2021	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	3385000	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	280000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	279000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1545000	usd
CY2023	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	0	usd
CY2022	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	0	usd
CY2021	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	10303000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1665000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-803000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-675000	usd
CY2023	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	1474000	usd
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	usd
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	usd
CY2023	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	89000	usd
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	usd
CY2021	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	19298000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	19098000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	17308000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1151000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4956000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	13136000	usd
CY2023	cwan	Increase Decrease In Deferred Commissions IncreaseDecreaseInDeferredCommissions	5067000	usd
CY2022	cwan	Increase Decrease In Deferred Commissions IncreaseDecreaseInDeferredCommissions	5845000	usd
CY2021	cwan	Increase Decrease In Deferred Commissions IncreaseDecreaseInDeferredCommissions	5161000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-115000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1609000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	361000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	1204000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	207000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-8050000	usd
CY2023	cwan	Increase Decrease In Tax Receivable Agreements IncreaseDecreaseInTaxReceivableAgreements	6000000	usd
CY2022	cwan	Increase Decrease In Tax Receivable Agreements IncreaseDecreaseInTaxReceivableAgreements	12200000	usd
CY2021	cwan	Increase Decrease In Tax Receivable Agreements IncreaseDecreaseInTaxReceivableAgreements	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	84602000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	58005000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3358000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5624000	usd
CY2021	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	usd
CY2022	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	usd
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	usd
CY2023	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	5950000	usd
CY2022	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
CY2021	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
CY2023	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	31801000	usd
CY2022	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	0	usd
CY2021	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	0	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	65793000	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-95055000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-76551000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5025000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1560000	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4738000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	18284000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2830000	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	20784000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3189000	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2185000	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	626000	usd
CY2023	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	4588000	usd
CY2022	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	4215000	usd
CY2021	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	0	usd
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	2749000	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	2750000	usd
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	434919000	usd
CY2023	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
CY2022	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
CY2021	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	2029000	usd
CY2023	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	55000000	usd
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1400000	usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	usd
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	582188000	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	214000	usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	5131000	usd
CY2023	cwan	Payment Of Tax Distributions To Continuing Equity Owners PaymentOfTaxDistributionsToContinuingEquityOwners	2184000	usd
CY2022	cwan	Payment Of Tax Distributions To Continuing Equity Owners PaymentOfTaxDistributionsToContinuingEquityOwners	117000	usd
CY2021	cwan	Payment Of Tax Distributions To Continuing Equity Owners PaymentOfTaxDistributionsToContinuingEquityOwners	0	usd
CY2023	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	2900000	usd
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-19291000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	16229000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	195288000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	785000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-1556000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-112000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-28959000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3873000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	193509000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	250724000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	254597000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	61088000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	221765000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	250724000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	254597000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	3454000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	1395000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	26113000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2432000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2044000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	802000	usd
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	435000	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	350000	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	322000	usd
CY2023	cwan	Business Acquisition Holdback Liability Included In Accrued Expense And Other Long Term Liabilities BusinessAcquisitionHoldbackLiabilityIncludedInAccruedExpenseAndOtherLongTermLiabilities	0	usd
CY2022	cwan	Business Acquisition Holdback Liability Included In Accrued Expense And Other Long Term Liabilities BusinessAcquisitionHoldbackLiabilityIncludedInAccruedExpenseAndOtherLongTermLiabilities	6999000	usd
CY2021	cwan	Business Acquisition Holdback Liability Included In Accrued Expense And Other Long Term Liabilities BusinessAcquisitionHoldbackLiabilityIncludedInAccruedExpenseAndOtherLongTermLiabilities	0	usd
CY2023	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0	usd
CY2022	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0	usd
CY2021	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	214000	usd
CY2023	cwan	Tax Distributions Psysblr To Continuing Equity Owners Included In Accrued Expenses TaxDistributionsPsysblrToContinuingEquityOwnersIncludedInAccruedExpenses	2945000	usd
CY2022	cwan	Tax Distributions Psysblr To Continuing Equity Owners Included In Accrued Expenses TaxDistributionsPsysblrToContinuingEquityOwnersIncludedInAccruedExpenses	3196000	usd
CY2021	cwan	Tax Distributions Psysblr To Continuing Equity Owners Included In Accrued Expenses TaxDistributionsPsysblrToContinuingEquityOwnersIncludedInAccruedExpenses	169000	usd
CY2023	cwan	Tax Liability Related To Organizational Transaction Included In Accrued Expenses TaxLiabilityRelatedToOrganizationalTransactionIncludedInAccruedExpenses	0	usd
CY2022	cwan	Tax Liability Related To Organizational Transaction Included In Accrued Expenses TaxLiabilityRelatedToOrganizationalTransactionIncludedInAccruedExpenses	0	usd
CY2021	cwan	Tax Liability Related To Organizational Transaction Included In Accrued Expenses TaxLiabilityRelatedToOrganizationalTransactionIncludedInAccruedExpenses	793000	usd
CY2021Q3	cwan	Percentage Of Expected Remaining Tax Benefits To Be Realized PercentageOfExpectedRemainingTaxBenefitsToBeRealized	0.15
CY2021Q3	cwan	Percentage Of Estimated Tax Benefits To Be Realized PercentageOfEstimatedTaxBenefitsToBeRealized	0.85
CY2023Q4	cwan	Contract Assets Current ContractAssetsCurrent	2800000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and the related disclosures at the date of the consolidated financial statements, as well as the reported amounts of revenue and expenses during the periods presented. Actual results could differ materially from those estimates.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Items subject to estimates and assumptions include the useful lives and recoverability of long-lived assets, the average period of benefit associated with deferred contract costs, sales reserves, the incremental borrowing rate applied in lease accounting, the fair value and probability of achieving performance conditions of equity awards, business combinations, tax valuation allowance and probability of making payments under the TRA, among others. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, the result of which forms the basis for making judgments about the carrying values of assets and liabilities, and measurement of revenues and expenses. To the extent there are material differences between these estimates, judgments, or assumptions and actual results, the Company’s consolidated financial statements will be affected.</span></div>
CY2023	cwan	Economic Benefit Period Of Revenue Contracts EconomicBenefitPeriodOfRevenueContracts	P4Y
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022Q4	cwan	Contract Assets Current ContractAssetsCurrent	2500000	usd
CY2023Q4	cwan	Contract Assets Non Current ContractAssetsNonCurrent	1900000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and accounts receivable. The Company maintains the vast majority of its cash with United States financial institutions of high credit quality. The Company performs periodic evaluations of the credit standing of such institutions.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are recorded net of an allowance for expected credit losses. Management’s evaluation of the adequacy of the allowance for expected credit losses considers historical collection experience, changes in customer payment terms, the aging of receivable balances, as well as current and expected economic conditions, all of which may impact a customer’s ability to pay. Receivables are written-off and charged against its recorded allowance when the Company has exhausted collection efforts without success.</span></div>
CY2022Q4	cwan	Contract Assets Non Current ContractAssetsNonCurrent	1200000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	100000	usd
CY2021	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	500000	usd
CY2021Q3	cwan	Percentage Of Estimated Tax Benefits To Be Realized PercentageOfEstimatedTaxBenefitsToBeRealized	0.85
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	700000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	100000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-100000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	3098000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1339000	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1100000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	400000	usd
CY2023Q4	cwan	Cash Adjusted Cost CashAdjustedCost	317676000	usd
CY2023Q4	cwan	Cash Unrealized Gains CashUnrealizedGains	122000	usd
CY2023Q4	cwan	Cash Unrealized Loss CashUnrealizedLoss	80000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	317717000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	221765000	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	74457000	usd
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	21495000	usd
CY2022Q4	cwan	Cash Adjusted Cost CashAdjustedCost	255614000	usd
CY2022Q4	cwan	Cash Unrealized Gains CashUnrealizedGains	0	usd
CY2022Q4	cwan	Cash Unrealized Loss CashUnrealizedLoss	0	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	255614000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	250724000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	4890000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	0	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	99900000	usd
CY2023Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	3000000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	99900000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	78400000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	21500000	usd
CY2023Q4	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue	3000000	usd
CY2022Q4	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	28890000	usd
CY2023	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	2700000	usd
CY2023	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	1100000	usd
CY2023	cwan	Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense Reversal DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpenseReversal	-700000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	43791000	usd
CY2023	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	253000	usd
CY2023	us-gaap	Goodwill Translation And Purchase Accounting Adjustments GoodwillTranslationAndPurchaseAccountingAdjustments	1294000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	45338000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	30686000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4553000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	26132000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	29803000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	347000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	29456000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4300000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	400000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	26132000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	4190000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	4038000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	4038000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	4038000	usd
CY2023Q4	cwan	Finite Lived Intangible Asset Expected Amortization Year Five And After Year Five FiniteLivedIntangibleAssetExpectedAmortizationYearFiveAndAfterYearFive	9828000	usd
CY2023Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	46595000	usd
CY2022Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	30963000	usd
CY2023Q4	us-gaap	Billed Contract Receivables BilledContractReceivables	45805000	usd
CY2022Q4	us-gaap	Billed Contract Receivables BilledContractReceivables	41718000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	309000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	106000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	92091000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	72575000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	11225000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	12551000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	4644000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	4215000	usd
CY2023Q4	cwan	Prepaid Management Fee Current PrepaidManagementFeeCurrent	2009000	usd
CY2022Q4	cwan	Prepaid Management Fee Current PrepaidManagementFeeCurrent	2396000	usd
CY2023Q4	cwan	Contract Assets Current ContractAssetsCurrent	2772000	usd
CY2022Q4	cwan	Contract Assets Current ContractAssetsCurrent	2518000	usd
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	4382000	usd
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	2602000	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1692000	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1540000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	959000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2335000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	27683000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	28157000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	33620000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	29516000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	18271000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	14452000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15349000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15064000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	500000	usd
CY2021Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	500000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	500000	usd
CY2023	us-gaap	Depreciation Depreciation	5700000	usd
CY2022	us-gaap	Depreciation Depreciation	4800000	usd
CY2021	us-gaap	Depreciation Depreciation	3500000	usd
CY2022	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	100000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Fair Value Disclosure PropertyPlantAndEquipmentFairValueDisclosure	0	usd
CY2023Q4	cwan	Prepaid Management Fee To Principal Equity Owners Noncurrent PrepaidManagementFeeToPrincipalEquityOwnersNoncurrent	0	usd
CY2022Q4	cwan	Prepaid Management Fee To Principal Equity Owners Noncurrent PrepaidManagementFeeToPrincipalEquityOwnersNoncurrent	2009000	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	1290000	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	861000	usd
CY2023Q4	cwan	Long Term Contract Asset LongTermContractAsset	1909000	usd
CY2022Q4	cwan	Long Term Contract Asset LongTermContractAsset	1191000	usd
CY2023Q4	cwan	Prepaid It Costs Noncurrent PrepaidItCostsNoncurrent	364000	usd
CY2022Q4	cwan	Prepaid It Costs Noncurrent PrepaidItCostsNoncurrent	259000	usd
CY2023Q4	cwan	Deferred Tax Assets Noncurrent DeferredTaxAssetsNoncurrent	1344000	usd
CY2022Q4	cwan	Deferred Tax Assets Noncurrent DeferredTaxAssetsNoncurrent	1560000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4907000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5880000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	3084000	usd
CY2023Q4	cwan	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	162000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	25659000	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	339000	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	408000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	622000	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	548000	usd
CY2023Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	11808000	usd
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	10005000	usd
CY2023Q4	cwan	Accrued Vendor Liabilities Current AccruedVendorLiabilitiesCurrent	6883000	usd
CY2022Q4	cwan	Accrued Vendor Liabilities Current AccruedVendorLiabilitiesCurrent	4811000	usd
CY2023Q4	cwan	Accrued Employee Benefits And Retirement Current AccruedEmployeeBenefitsAndRetirementCurrent	10329000	usd
CY2022Q4	cwan	Accrued Employee Benefits And Retirement Current AccruedEmployeeBenefitsAndRetirementCurrent	10566000	usd
CY2023Q4	cwan	Acquisition Holdback Liability Current AcquisitionHoldbackLiabilityCurrent	4679000	usd
CY2022Q4	cwan	Acquisition Holdback Liability Current AcquisitionHoldbackLiabilityCurrent	3770000	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2766000	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1185000	usd
CY2023Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	3415000	usd
CY2022Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	2709000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	456000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	920000	usd
CY2023Q4	cwan	Tax Distributions Payable TaxDistributionsPayable	2945000	usd
CY2022Q4	cwan	Tax Distributions Payable TaxDistributionsPayable	3196000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5293000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4001000	usd
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	49535000	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	42119000	usd
CY2023Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	161000	usd
CY2022Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	119000	usd
CY2023Q4	cwan	Acquisition Holdback Liability Non Current AcquisitionHoldbackLiabilityNonCurrent	0	usd
CY2022Q4	cwan	Acquisition Holdback Liability Non Current AcquisitionHoldbackLiabilityNonCurrent	3496000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	5356000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	5932000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5518000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	9547000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2160000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	23499000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6551000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	16948000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	2750000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2750000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	2750000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	43313000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	46063000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	235000	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	45828000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	48578000	usd
CY2023	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	6700000	usd
CY2022	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	5600000	usd
CY2021	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	4500000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2023	cwan	Operating Lease Initial Term OperatingLeaseInitialTerm	P12M
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	usd
CY2022Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	27032000	usd
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	usd
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	7600000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	6400000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	7578000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	7727000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	7108000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y4M17D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y2M15D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0470
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0398
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	7241000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	4949000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4604000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2936000	usd
CY2023Q4	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	9058000	usd
CY2023Q4	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	8289000	usd
CY2023Q4	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	2577000	usd
CY2023Q4	us-gaap	Purchase Obligation Due In Fourth Year PurchaseObligationDueInFourthYear	160000	usd
CY2023Q4	us-gaap	Purchase Obligation Due In Fifth Year PurchaseObligationDueInFifthYear	62000	usd
CY2023Q4	us-gaap	Purchase Obligation PurchaseObligation	20146000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-23083000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-6695000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-8094000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2829000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1456000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1272000	usd
CY2021Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2710000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-21627000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-21627000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7967000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-7967000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-8213000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8213000	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	56058717	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	64103454	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	74880280	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14893172	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.60
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y2M8D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	116029000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	10303307	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	13.49
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1124740	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.35
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	16346000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1756568	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	7.23
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	22315171	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.52
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y3M
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	322877000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	43986	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	18.19
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2950662	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	7.45
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	31341000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1653725	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	11.16
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	17754770	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.47
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y21D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	183315000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	3016765	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	6.90
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	33792000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1492651	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	13.12
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	13245354	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.31
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y7M24D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	155438000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	9693376	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.68
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	119799000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.74
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.11
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	14400000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y2M12D
CY2021Q3	cwan	Share Based Compensation Arrangement By Share Based Payment Award Vesting Conditions Modified Options Number ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingConditionsModifiedOptionsNumber	12493241	shares
CY2023Q4	cwan	Share Based Compensation Arrangement By Share Based Payment Award Number Of Installments ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfInstallments	3	installment
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	7.74
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	5.11
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y6M
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.44
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.42
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.018
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.020
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.006
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.013
CY2022	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	41000	usd
CY2021	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	-643000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1583000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1592000	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1935000	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	16000	usd
CY2023Q4	cwan	Number Of Business Activities NumberOfBusinessActivities	1	activity
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	368168000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	303426000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	252022000	usd
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	64035000	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	68634000	usd
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	10738000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-11383000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-9306000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-11117000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-11483000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	3971000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	3510000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-22866000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5335000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7607000	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	92000	usd
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	54000	usd
CY2023	cwan	Effective Income Tax Rate Reconciliation Executive Compensation Deduction Amount EffectiveIncomeTaxRateReconciliationExecutiveCompensationDeductionAmount	10985000	usd
CY2022	cwan	Effective Income Tax Rate Reconciliation Executive Compensation Deduction Amount EffectiveIncomeTaxRateReconciliationExecutiveCompensationDeductionAmount	5544000	usd
CY2021	cwan	Effective Income Tax Rate Reconciliation Executive Compensation Deduction Amount EffectiveIncomeTaxRateReconciliationExecutiveCompensationDeductionAmount	0	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	761000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	491000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	111000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1121000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1737000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1055000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1882000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2228000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1166000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-7000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-3000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-13000	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-1658000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-865000	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-666000	usd
CY2023	cwan	Adjustment Of Deferred Income Tax Expense Benefit AdjustmentOfDeferredIncomeTaxExpenseBenefit	-1665000	usd
CY2022	cwan	Adjustment Of Deferred Income Tax Expense Benefit AdjustmentOfDeferredIncomeTaxExpenseBenefit	-868000	usd
CY2021	cwan	Adjustment Of Deferred Income Tax Expense Benefit AdjustmentOfDeferredIncomeTaxExpenseBenefit	-679000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	217000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1360000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	487000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4802000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1120000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1597000	usd
CY2023	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	-349000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Gilti Amount EffectiveIncomeTaxRateReconciliationGiltiAmount	0	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Gilti Amount EffectiveIncomeTaxRateReconciliationGiltiAmount	1854000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Gilti Amount EffectiveIncomeTaxRateReconciliationGiltiAmount	845000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-1604000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-2316000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-1746000	usd
CY2023	cwan	Income Tax Reconciliation Permanent Items IncomeTaxReconciliationPermanentItems	185000	usd
CY2022	cwan	Income Tax Reconciliation Permanent Items IncomeTaxReconciliationPermanentItems	394000	usd
CY2021	cwan	Income Tax Reconciliation Permanent Items IncomeTaxReconciliationPermanentItems	-57000	usd
CY2023	cwan	Income Tax Reconciliation Taxcredits And Incentives IncomeTaxReconciliationTaxcreditsAndIncentives	3929000	usd
CY2022	cwan	Income Tax Reconciliation Taxcredits And Incentives IncomeTaxReconciliationTaxcreditsAndIncentives	1623000	usd
CY2021	cwan	Income Tax Reconciliation Taxcredits And Incentives IncomeTaxReconciliationTaxcreditsAndIncentives	55000	usd
CY2023	cwan	Income Tax Reconciliation Return To Provision IncomeTaxReconciliationReturnToProvision	70000	usd
CY2022	cwan	Income Tax Reconciliation Return To Provision IncomeTaxReconciliationReturnToProvision	-38107000	usd
CY2021	cwan	Income Tax Reconciliation Return To Provision IncomeTaxReconciliationReturnToProvision	-320000	usd
CY2023	cwan	Income Tax Reconciliation Changes In Tax Law IncomeTaxReconciliationChangesInTaxLaw	-3303000	usd
CY2022	cwan	Income Tax Reconciliation Changes In Tax Law IncomeTaxReconciliationChangesInTaxLaw	63504000	usd
CY2021	cwan	Income Tax Reconciliation Changes In Tax Law IncomeTaxReconciliationChangesInTaxLaw	0	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3804000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-25356000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4652000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	29000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	127000	usd
CY2021	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	3000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	217000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1360000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	487000	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.009
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.255
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.064
CY2023Q4	cwan	Deferred Tax Assets Tax Credit Carryforwards Investment In Partnership DeferredTaxAssetsTaxCreditCarryforwardsInvestmentInPartnership	409924000	usd
CY2022Q4	cwan	Deferred Tax Assets Tax Credit Carryforwards Investment In Partnership DeferredTaxAssetsTaxCreditCarryforwardsInvestmentInPartnership	336276000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	86807000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	80711000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	11992000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	8336000	usd
CY2023Q4	cwan	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	2657000	usd
CY2022Q4	cwan	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	2057000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1563000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1099000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	512943000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	428479000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	506494000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	422555000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	6449000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	5924000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	6495000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	7364000	usd
CY2023Q4	cwan	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	2624000	usd
CY2022Q4	cwan	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	1988000	usd
CY2023Q4	cwan	Deferred Tax Liabilities Revenue DeferredTaxLiabilitiesRevenue	1252000	usd
CY2022Q4	cwan	Deferred Tax Liabilities Revenue DeferredTaxLiabilitiesRevenue	833000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	90000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	111000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	10461000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	10296000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	4012000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	4372000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	84000000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3932000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3548000	usd
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	2423000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	959000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	89000	usd
CY2023	cwan	Unrecognized Tax Benefits Increases Resulting From Organizational Transactions UnrecognizedTaxBenefitsIncreasesResultingFromOrganizationalTransactions	666000	usd
CY2022	cwan	Unrecognized Tax Benefits Increases Resulting From Organizational Transactions UnrecognizedTaxBenefitsIncreasesResultingFromOrganizationalTransactions	0	usd
CY2021	cwan	Unrecognized Tax Benefits Increases Resulting From Organizational Transactions UnrecognizedTaxBenefitsIncreasesResultingFromOrganizationalTransactions	3455000	usd
CY2023	cwan	Unrecognized Tax Benefits Increases Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions	182000	usd
CY2022	cwan	Unrecognized Tax Benefits Increases Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions	-182000	usd
CY2021	cwan	Unrecognized Tax Benefits Increases Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions	3000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	487000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	487000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Foreign Currency Translation UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation	149000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Foreign Currency Translation UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation	94000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Foreign Currency Translation UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation	1000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6865000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3932000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3548000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	500000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2021Q3	cwan	Percentage Of Estimated Tax Benefits To Be Realized PercentageOfEstimatedTaxBenefitsToBeRealized	0.85
CY2021Q3	cwan	Percentage Of Expected Remaining Tax Benefits To Be Realized PercentageOfExpectedRemainingTaxBenefitsToBeRealized	0.15
CY2023	cwan	Estimated Future Tax Expense Benefit Related To Ownership Exchanges EstimatedFutureTaxExpenseBenefitRelatedToOwnershipExchanges	-460000000	usd
CY2023	cwan	Estimated Future Tax Expense Benefit Related To Ownership Exchanges Associated To Tax Receivable Agreement Liability EstimatedFutureTaxExpenseBenefitRelatedToOwnershipExchangesAssociatedToTaxReceivableAgreementLiability	-391000000	usd
CY2023Q4	cwan	Tax Receivable Agreement Liability For Future Period TaxReceivableAgreementLiabilityForFuturePeriod	0	usd
CY2022Q4	cwan	Tax Receivable Agreement Liability Noncurrent TaxReceivableAgreementLiabilityNoncurrent	12200000	usd
CY2021Q4	cwan	Tax Receivable Agreement Liability Noncurrent TaxReceivableAgreementLiabilityNoncurrent	0	usd
CY2020Q4	cwan	Tax Receivable Agreement Liability Noncurrent TaxReceivableAgreementLiabilityNoncurrent	0	usd
CY2023	cwan	Payments Of Tax Receivable Agreement Liability PaymentsOfTaxReceivableAgreementLiability	-8396000	usd
CY2022	cwan	Payments Of Tax Receivable Agreement Liability PaymentsOfTaxReceivableAgreementLiability	0	usd
CY2021	cwan	Payments Of Tax Receivable Agreement Liability PaymentsOfTaxReceivableAgreementLiability	0	usd
CY2023Q4	cwan	Tax Receivable Agreement Liability Noncurrent TaxReceivableAgreementLiabilityNoncurrent	18894000	usd
CY2022Q4	cwan	Tax Receivable Agreement Liability Noncurrent TaxReceivableAgreementLiabilityNoncurrent	12200000	usd
CY2021Q4	cwan	Tax Receivable Agreement Liability Noncurrent TaxReceivableAgreementLiabilityNoncurrent	0	usd
CY2023	cwan	Tax Receivable Agreement Expense TaxReceivableAgreementExpense	14396000	usd
CY2022	cwan	Tax Receivable Agreement Expense TaxReceivableAgreementExpense	11639000	usd
CY2021	cwan	Tax Receivable Agreement Expense TaxReceivableAgreementExpense	0	usd
CY2023	cwan	Tax Receivable Agreement Bonus TaxReceivableAgreementBonus	694000	usd
CY2022	cwan	Tax Receivable Agreement Bonus TaxReceivableAgreementBonus	561000	usd
CY2021	cwan	Tax Receivable Agreement Bonus TaxReceivableAgreementBonus	0	usd
CY2023	cwan	Tax Receivable Agreement Expense And Bonus TaxReceivableAgreementExpenseAndBonus	15090000	usd
CY2022	cwan	Tax Receivable Agreement Expense And Bonus TaxReceivableAgreementExpenseAndBonus	12200000	usd
CY2021	cwan	Tax Receivable Agreement Expense And Bonus TaxReceivableAgreementExpenseAndBonus	0	usd
CY2023	cwan	Accrued Tax Distribution Payable AccruedTaxDistributionPayable	2900000	usd
CY2022	cwan	Accrued Tax Distribution Payable AccruedTaxDistributionPayable	3200000	usd
CY2023	cwan	Tra Payments Payable To Certain Continuing Equity Owners TraPaymentsPayableToCertainContinuingEquityOwners	14400000	usd
CY2022	cwan	Tra Payments Payable To Certain Continuing Equity Owners TraPaymentsPayableToCertainContinuingEquityOwners	11600000	usd
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001628280-24-007825-index-headers.html	Edgar Link	pending
0001628280-24-007825-index.html	Edgar Link	pending
0001628280-24-007825.txt	Edgar Link	pending
0001628280-24-007825-xbrl.zip	Edgar Link	pending
a2022clearwater-employme.htm	Edgar Link	pending
a2022clearwater-employme001.jpg	Edgar Link	pending
a2022clearwater-employme002.jpg	Edgar Link	pending
a2022clearwater-employme003.jpg	Edgar Link	pending
a2022clearwater-employme004.jpg	Edgar Link	pending
a2022clearwater-employme005.jpg	Edgar Link	pending
a2022clearwater-employme006.jpg	Edgar Link	pending
a2022clearwater-employme007.jpg	Edgar Link	pending
a2022clearwater-employme008.jpg	Edgar Link	pending
a2022clearwater-employme009.jpg	Edgar Link	pending
a2022clearwater-employme010.jpg	Edgar Link	pending
a2022clearwater-employme011.jpg	Edgar Link	pending
a2022clearwater-employme012.jpg	Edgar Link	pending
a2022clearwater-employme013.jpg	Edgar Link	pending
a2022clearwater-employme014.jpg	Edgar Link	pending
a2022clearwater-employme015.jpg	Edgar Link	pending
amendmentno1ofcreditagre.htm	Edgar Link	pending
amendmentno1ofcreditagre001.jpg	Edgar Link	pending
amendmentno1ofcreditagre002.jpg	Edgar Link	pending
amendmentno1ofcreditagre003.jpg	Edgar Link	pending
amendmentno1ofcreditagre004.jpg	Edgar Link	pending
amendmentno1ofcreditagre005.jpg	Edgar Link	pending
amendmentno1ofcreditagre006.jpg	Edgar Link	pending
amendmentno1ofcreditagre007.jpg	Edgar Link	pending
amendmentno1ofcreditagre008.jpg	Edgar Link	pending
amendmentno1ofcreditagre009.jpg	Edgar Link	pending
amendmentno1ofcreditagre010.jpg	Edgar Link	pending
amendmentno1ofcreditagre011.jpg	Edgar Link	pending
amendmentno1ofcreditagre012.jpg	Edgar Link	pending
amendmentno1ofcreditagre013.jpg	Edgar Link	pending
amendmentno1ofcreditagre014.jpg	Edgar Link	pending
amendmentno1ofcreditagre015.jpg	Edgar Link	pending
amendmentno1ofcreditagre016.jpg	Edgar Link	pending
amendmentno1ofcreditagre017.jpg	Edgar Link	pending
amendmentno1ofcreditagre018.jpg	Edgar Link	pending
amendmentno1ofcreditagre019.jpg	Edgar Link	pending
amendmentno1ofcreditagre020.jpg	Edgar Link	pending
amendmentno1ofcreditagre021.jpg	Edgar Link	pending
amendmentno1ofcreditagre022.jpg	Edgar Link	pending
amendmentno1ofcreditagre023.jpg	Edgar Link	pending
amendmentno1ofcreditagre024.jpg	Edgar Link	pending
amendmentno1ofcreditagre025.jpg	Edgar Link	pending
amendmentno1ofcreditagre026.jpg	Edgar Link	pending
amendmentno1ofcreditagre027.jpg	Edgar Link	pending
amendmentno1ofcreditagre028.jpg	Edgar Link	pending
amendmentno1ofcreditagre029.jpg	Edgar Link	pending
amendmentno1ofcreditagre030.jpg	Edgar Link	pending
amendmentno1ofcreditagre031.jpg	Edgar Link	pending
amendmentno1ofcreditagre032.jpg	Edgar Link	pending
amendmentno1ofcreditagre033.jpg	Edgar Link	pending
amendmentno1ofcreditagre034.jpg	Edgar Link	pending
amendmentno1ofcreditagre035.jpg	Edgar Link	pending
amendmentno1ofcreditagre036.jpg	Edgar Link	pending
amendmentno1ofcreditagre037.jpg	Edgar Link	pending
amendmentno1ofcreditagre038.jpg	Edgar Link	pending
amendmentno1ofcreditagre039.jpg	Edgar Link	pending
amendmentno1ofcreditagre040.jpg	Edgar Link	pending
amendmentno1ofcreditagre041.jpg	Edgar Link	pending
amendmentno1ofcreditagre042.jpg	Edgar Link	pending
amendmentno1ofcreditagre043.jpg	Edgar Link	pending
amendmentno1ofcreditagre044.jpg	Edgar Link	pending
amendmentno1ofcreditagre045.jpg	Edgar Link	pending
amendmentno1ofcreditagre046.jpg	Edgar Link	pending
amendmentno1ofcreditagre047.jpg	Edgar Link	pending
amendmentno1ofcreditagre048.jpg	Edgar Link	pending
amendmentno1ofcreditagre049.jpg	Edgar Link	pending
amendmentno1ofcreditagre050.jpg	Edgar Link	pending
amendmentno1ofcreditagre051.jpg	Edgar Link	pending
amendmentno1ofcreditagre052.jpg	Edgar Link	pending
amendmentno1ofcreditagre053.jpg	Edgar Link	pending
amendmentno1ofcreditagre054.jpg	Edgar Link	pending
amendmentno1ofcreditagre055.jpg	Edgar Link	pending
amendmentno1ofcreditagre056.jpg	Edgar Link	pending
amendmentno1ofcreditagre057.jpg	Edgar Link	pending
amendmentno1ofcreditagre058.jpg	Edgar Link	pending
amendmentno1ofcreditagre059.jpg	Edgar Link	pending
amendmentno1ofcreditagre060.jpg	Edgar Link	pending
amendmentno1ofcreditagre061.jpg	Edgar Link	pending
amendmentno1ofcreditagre062.jpg	Edgar Link	pending
amendmentno1ofcreditagre063.jpg	Edgar Link	pending
amendmentno1ofcreditagre064.jpg	Edgar Link	pending
amendmentno1ofcreditagre065.jpg	Edgar Link	pending
amendmentno1ofcreditagre066.jpg	Edgar Link	pending
amendmentno1ofcreditagre067.jpg	Edgar Link	pending
amendmentno1ofcreditagre068.jpg	Edgar Link	pending
amendmentno1ofcreditagre069.jpg	Edgar Link	pending
amendmentno1ofcreditagre070.jpg	Edgar Link	pending
amendmentno1ofcreditagre071.jpg	Edgar Link	pending
amendmentno1ofcreditagre072.jpg	Edgar Link	pending
amendmentno1ofcreditagre073.jpg	Edgar Link	pending
amendmentno1ofcreditagre074.jpg	Edgar Link	pending
amendmentno1ofcreditagre075.jpg	Edgar Link	pending
amendmentno1ofcreditagre076.jpg	Edgar Link	pending
amendmentno1ofcreditagre077.jpg	Edgar Link	pending
amendmentno1ofcreditagre078.jpg	Edgar Link	pending
amendmentno1ofcreditagre079.jpg	Edgar Link	pending
amendmentno1ofcreditagre080.jpg	Edgar Link	pending
amendmentno1ofcreditagre081.jpg	Edgar Link	pending
amendmentno1ofcreditagre082.jpg	Edgar Link	pending
amendmentno1ofcreditagre083.jpg	Edgar Link	pending
amendmentno1ofcreditagre084.jpg	Edgar Link	pending
amendmentno1ofcreditagre085.jpg	Edgar Link	pending
amendmentno1ofcreditagre086.jpg	Edgar Link	pending
amendmentno1ofcreditagre087.jpg	Edgar Link	pending
amendmentno1ofcreditagre088.jpg	Edgar Link	pending
amendmentno1ofcreditagre089.jpg	Edgar Link	pending
amendmentno1ofcreditagre090.jpg	Edgar Link	pending
amendmentno1ofcreditagre091.jpg	Edgar Link	pending
amendmentno1ofcreditagre092.jpg	Edgar Link	pending
amendmentno1ofcreditagre093.jpg	Edgar Link	pending
amendmentno1ofcreditagre094.jpg	Edgar Link	pending
amendmentno1ofcreditagre095.jpg	Edgar Link	pending
amendmentno1ofcreditagre096.jpg	Edgar Link	pending
amendmentno1ofcreditagre097.jpg	Edgar Link	pending
amendmentno1ofcreditagre098.jpg	Edgar Link	pending
amendmentno1ofcreditagre099.jpg	Edgar Link	pending
amendmentno1ofcreditagre100.jpg	Edgar Link	pending
amendmentno1ofcreditagre101.jpg	Edgar Link	pending
amendmentno1ofcreditagre102.jpg	Edgar Link	pending
amendmentno1ofcreditagre103.jpg	Edgar Link	pending
amendmentno1ofcreditagre104.jpg	Edgar Link	pending
amendmentno1ofcreditagre105.jpg	Edgar Link	pending
amendmentno1ofcreditagre106.jpg	Edgar Link	pending
amendmentno1ofcreditagre107.jpg	Edgar Link	pending
amendmentno1ofcreditagre108.jpg	Edgar Link	pending
amendmentno1ofcreditagre109.jpg	Edgar Link	pending
amendmentno1ofcreditagre110.jpg	Edgar Link	pending
amendmentno1ofcreditagre111.jpg	Edgar Link	pending
amendmentno1ofcreditagre112.jpg	Edgar Link	pending
amendmentno1ofcreditagre113.jpg	Edgar Link	pending
amendmentno1ofcreditagre114.jpg	Edgar Link	pending
amendmentno1ofcreditagre115.jpg	Edgar Link	pending
amendmentno1ofcreditagre116.jpg	Edgar Link	pending
amendmentno1ofcreditagre117.jpg	Edgar Link	pending
amendmentno1ofcreditagre118.jpg	Edgar Link	pending
amendmentno1ofcreditagre119.jpg	Edgar Link	pending
amendmentno1ofcreditagre120.jpg	Edgar Link	pending
amendmentno1ofcreditagre121.jpg	Edgar Link	pending
amendmentno1ofcreditagre122.jpg	Edgar Link	pending
amendmentno1ofcreditagre123.jpg	Edgar Link	pending
amendmentno1ofcreditagre124.jpg	Edgar Link	pending
amendmentno1ofcreditagre125.jpg	Edgar Link	pending
amendmentno1ofcreditagre126.jpg	Edgar Link	pending
amendmentno1ofcreditagre127.jpg	Edgar Link	pending
amendmentno1ofcreditagre128.jpg	Edgar Link	pending
amendmentno1ofcreditagre129.jpg	Edgar Link	pending
amendmentno1ofcreditagre130.jpg	Edgar Link	pending
amendmentno1ofcreditagre131.jpg	Edgar Link	pending
amendmentno1ofcreditagre132.jpg	Edgar Link	pending
amendmentno1ofcreditagre133.jpg	Edgar Link	pending
amendmentno1ofcreditagre134.jpg	Edgar Link	pending
amendmentno1ofcreditagre135.jpg	Edgar Link	pending
amendmentno1ofcreditagre136.jpg	Edgar Link	pending
amendmentno1ofcreditagre137.jpg	Edgar Link	pending
amendmentno1ofcreditagre138.jpg	Edgar Link	pending
amendmentno1ofcreditagre139.jpg	Edgar Link	pending
amendmentno1ofcreditagre140.jpg	Edgar Link	pending
amendmentno1ofcreditagre141.jpg	Edgar Link	pending
amendmentno1ofcreditagre142.jpg	Edgar Link	pending
amendmentno1ofcreditagre143.jpg	Edgar Link	pending
amendmentno1ofcreditagre144.jpg	Edgar Link	pending
amendmentno1ofcreditagre145.jpg	Edgar Link	pending
amendmentno1ofcreditagre146.jpg	Edgar Link	pending
amendmentno1ofcreditagre147.jpg	Edgar Link	pending
amendmentno1ofcreditagre148.jpg	Edgar Link	pending
amendmentno1ofcreditagre149.jpg	Edgar Link	pending
amendmentno1ofcreditagre150.jpg	Edgar Link	pending
amendmentno1ofcreditagre151.jpg	Edgar Link	pending
amendmentno1ofcreditagre152.jpg	Edgar Link	pending
amendmentno1ofcreditagre153.jpg	Edgar Link	pending
amendmentno1ofcreditagre154.jpg	Edgar Link	pending
amendmentno1ofcreditagre155.jpg	Edgar Link	pending
amendmentno1ofcreditagre156.jpg	Edgar Link	pending
amendmentno1ofcreditagre157.jpg	Edgar Link	pending
amendmentno1ofcreditagre158.jpg	Edgar Link	pending
amendmentno1ofcreditagre159.jpg	Edgar Link	pending
amendmentno1ofcreditagre160.jpg	Edgar Link	pending
amendmentno1ofcreditagre161.jpg	Edgar Link	pending
amendmentno1ofcreditagre162.jpg	Edgar Link	pending
amendmentno1ofcreditagre163.jpg	Edgar Link	pending
amendmentno1ofcreditagre164.jpg	Edgar Link	pending
amendmentno1ofcreditagre165.jpg	Edgar Link	pending
amendmentno1ofcreditagre166.jpg	Edgar Link	pending
amendmentno1ofcreditagre167.jpg	Edgar Link	pending
amendmentno1ofcreditagre168.jpg	Edgar Link	pending
amendmentno1ofcreditagre169.jpg	Edgar Link	pending
amendmentno1ofcreditagre170.jpg	Edgar Link	pending
amendmentno1ofcreditagre171.jpg	Edgar Link	pending
amendmentno1ofcreditagre172.jpg	Edgar Link	pending
amendmentno1ofcreditagre173.jpg	Edgar Link	pending
amendmentno1ofcreditagre174.jpg	Edgar Link	pending
amendmentno1ofcreditagre175.jpg	Edgar Link	pending
amendmentno1ofcreditagre176.jpg	Edgar Link	pending
amendmentno1ofcreditagre177.jpg	Edgar Link	pending
amendmentno1ofcreditagre178.jpg	Edgar Link	pending
amendmentno1ofcreditagre179.jpg	Edgar Link	pending
amendmentno1ofcreditagre180.jpg	Edgar Link	pending
amendmentno1ofcreditagre181.jpg	Edgar Link	pending
amendmentno1ofcreditagre182.jpg	Edgar Link	pending
amendmentno1ofcreditagre183.jpg	Edgar Link	pending
amendmentno1ofcreditagre184.jpg	Edgar Link	pending
amendmentno1ofcreditagre185.jpg	Edgar Link	pending
amendmentno1ofcreditagre186.jpg	Edgar Link	pending
amendmentno1ofcreditagre187.jpg	Edgar Link	pending
amendmentno1ofcreditagre188.jpg	Edgar Link	pending
amendmentno1ofcreditagre189.jpg	Edgar Link	pending
amendmentno1ofcreditagre190.jpg	Edgar Link	pending
amendmentno1ofcreditagre191.jpg	Edgar Link	pending
amendmentno1ofcreditagre192.jpg	Edgar Link	pending
amendmentno1ofcreditagre193.jpg	Edgar Link	pending
amendmentno1ofcreditagre194.jpg	Edgar Link	pending
amendmentno1ofcreditagre195.jpg	Edgar Link	pending
amendmentno1ofcreditagre196.jpg	Edgar Link	pending
amendmentno1ofcreditagre197.jpg	Edgar Link	pending
amendmentno1ofcreditagre198.jpg	Edgar Link	pending
amendmentno1ofcreditagre199.jpg	Edgar Link	pending
amendmentno1ofcreditagre200.jpg	Edgar Link	pending
amendmentno1ofcreditagre201.jpg	Edgar Link	pending
amendmentno1ofcreditagre202.jpg	Edgar Link	pending
amendmentno1ofcreditagre203.jpg	Edgar Link	pending
amendmentno1ofcreditagre204.jpg	Edgar Link	pending
amendmentno1ofcreditagre205.jpg	Edgar Link	pending
amendmentno1ofcreditagre206.jpg	Edgar Link	pending
amendmentno1ofcreditagre207.jpg	Edgar Link	pending
amendmentno1ofcreditagre208.jpg	Edgar Link	pending
amendmentno1ofcreditagre209.jpg	Edgar Link	pending
amendmentno1ofcreditagre210.jpg	Edgar Link	pending
amendmentno1ofcreditagre211.jpg	Edgar Link	pending
amendmentno1ofcreditagre212.jpg	Edgar Link	pending
amendmentno1ofcreditagre213.jpg	Edgar Link	pending
clearwaterclawbackpolicy.htm	Edgar Link	pending
clearwaterclawbackpolicy001.jpg	Edgar Link	pending
clearwaterclawbackpolicy002.jpg	Edgar Link	pending
clearwaterclawbackpolicy003.jpg	Edgar Link	pending
clearwaterclawbackpolicy004.jpg	Edgar Link	pending
cwan-20231231.htm	Edgar Link	pending
cwan-20231231.xsd	Edgar Link	pending
cwan-20231231xexx311.htm	Edgar Link	pending
cwan-20231231xexx312.htm	Edgar Link	pending
cwan-20231231xexx321.htm	Edgar Link	pending
cwan-20231231xexx322.htm	Edgar Link	pending
cwan-20231231_g1.jpg	Edgar Link	pending
cwan-20231231_g2.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fy23consent_202402272208.htm	Edgar Link	pending
fy23consent_202402272208001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
cwan-20231231_pre.xml	Edgar Link	unprocessable
cwan-20231231_htm.xml	Edgar Link	completed
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cwan-20231231_cal.xml	Edgar Link	unprocessable
cwan-20231231_def.xml	Edgar Link	unprocessable
cwan-20231231_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CWAN
Clearwater Analytics Holdings, Inc. Stock $cwan

2023 Q4 Form 10-K Financial Statement

#000162828024007825 Filed on February 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CWAN Clearwater Analytics Holdings, Inc. Stock $cwan

2023 Q4 Form 10-K Financial Statement

#000162828024007825 Filed on February 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CWAN
Clearwater Analytics Holdings, Inc. Stock $cwan